SGPL1 and cystic fibrosis: Herein, we show in vivo and in vitro experiments supporting S1P modulation as suitable strategy to counteract inflammation and infection in CF, and we characterized the biochemical and structural properties of AfuSPL and hSPL in the recombinant purified form.